Champions Oncology (CSBR) Operating Income (2016 - 2025)
Historic Operating Income for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $185000.0.
- Champions Oncology's Operating Income fell 7472.68% to $185000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.2 million, marking a year-over-year increase of 37318.93%. This contributed to the annual value of $4.6 million for FY2025, which is 16189.51% up from last year.
- According to the latest figures from Q4 2025, Champions Oncology's Operating Income is $185000.0, which was down 7472.68% from -$527000.0 recorded in Q3 2025.
- Champions Oncology's 5-year Operating Income high stood at $4.5 million for Q1 2025, and its period low was -$2.6 million during Q1 2024.
- Moreover, its 5-year median value for Operating Income was -$277500.0 (2022), whereas its average is -$372950.0.
- Per our database at Business Quant, Champions Oncology's Operating Income soared by 365714.29% in 2021 and then tumbled by 2802857.14% in 2023.
- Champions Oncology's Operating Income (Quarter) stood at $263000.0 in 2021, then crashed by 97.34% to $7000.0 in 2022, then tumbled by 28028.57% to -$2.0 million in 2023, then soared by 137.44% to $732000.0 in 2024, then plummeted by 74.73% to $185000.0 in 2025.
- Its Operating Income stands at $185000.0 for Q4 2025, versus -$527000.0 for Q3 2025 and -$2.0 million for Q2 2025.